The DOI matches its Crossref record.
Indications of prevalence, practice and effects of anabolic steroid use in Great Britain.
Abstract
A growing number of reports of anabolic-androgenic streroid (AS) use in Great Britain (GB) among non-competitive groups have emerged since the beginning of 1990s. A study was commissioned by the Departments of Health for England, Scotland and Wales, to explore the extent and uses of AS from the public health point of view. As a part of a wider investigation into AS use, 21 gymnasia in England, Scotland and Wales were surveyed by questionnaire. The response rate was 59%. We found that of the 1667 participants, 9.1% of the men and 2.3% of the women had taken AS at some time and 6% of the men and 1.4% of the women were current users. Considerable variation in the prevalence of use was found, ranging from no reports in three of the gymnasia, up to 46%. We also investigated patterns of AS use and perceived side-effects in a wide-ranging group of AS users (n = 110), who were recruited through social networks. In-depth interviews with the users revealed that the 97 men (27+/-7 years) and 13 women (25+/-5 years) had been using AS regularly for 2.05+/-1.7 years and 1.9+/-2 years, respectively. Seventy-two injected AS. While most injected themselves, 25% were mainly injected by their friend. Up to 16 different drugs were taken by interviewees during the present or last cycle. Polydrug use was common and dosage taken exceeded therapeutic recommendations. Sixteen interviewees did not report side-effects, while the majority reported two or more. Many of these were cosmetic. Of the 97 men interviewed, 56% reported testicular atrophy, 52% gynaecomastia, 36% elevated blood pressure, 56% fluid retention, 26% injuries to tendons, 22% nosebleeds and 16% more frequent colds. Six men reported problems with kidney function and five with liver function. Problems with sleep were reported by 37%. Of the 13 women interviewed, eight reported menstrual irregularities, eight fluid retention, four clitoral enlargement, three decreased breast size and two elevated blood pressure. Four reported sleeplessness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“female athletes and transsexuals taking androgens show atrophy of mammary gland epithelial tissue (202, 203).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [202]
Citations
Cited by
Sorted by citations
Items 101–144 of 144
Ethics of prescribing drugs to enhance sporting performance
Kennedy, M., & Kennedy, J. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb123600.x · Cited by 4
Lewanowitsch, T., & Irvine, R. J. (2001) · Addiction Biology · doi:10.1080/13556210020020120 · Cited by 3
Doping Behaviour as an Indicator of Performance Pressure
Laure, P., & Allouche, S. (2015) · Palgrave Macmillan UK eBooks · doi:10.1057/9781137530073_9 · Cited by 3
Usman, H., Rashid, F. A., Ayub, H., et al. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Laure, P., Binsinger, C., & Scanff, C. L. (2004) · Science & Sports · doi:10.1016/j.scispo.2003.09.001 · Cited by 3
Anabolic agent use in adults with cystic fibrosis
Green, H. D., Barry, P. J., & Jones, A. M. (2015) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2015.07.014 · Cited by 3
Tatsugi, M. T. Y. (2013) · Journal of Sports Medicine & Doping Studies · doi:10.4172/2161-0673.1000122 · Cited by 3
Davies, S. E., & Craig, C. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545955.012 · Cited by 4
Doping-Epidemiologie in Fitnessstudios im Großraum Würzburg
Raschka, C. J., Hoffmann, A., & Andre, J. (2019) · Rechtsmedizin · doi:10.1007/s00194-019-00348-1 · Cited by 3
Conduites dopantes: quelques modalités de consommation des produits
Laure, P. (2001) · Revue Française des Laboratoires · doi:10.1016/s0338-9898(01)80051-2 · Cited by 3
10.1016/b978-1-4160-2911-3.50027-3
(2000) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50027-3 · Cited by 2
Andrew, B. (2012) · InTech eBooks · doi:10.5772/25536 · Cited by 2
Effect of Chronic Use of Recreational Drugs on the Sperm Count in Albino Mice
Purkayastha, S., & Mahanta, R. (2014) · International Journal of Sciences: Basic and Applied Research · Cited by 2
Determinants of drug use in sport: a survey of Italian athletes
Torre, G. L., Limongelli, F. M., Masala, D., et al. (2024) · Italian Journal of Public Health · doi:10.2427/6015 · Cited by 2
Posiadała, D., Smorawiński, J., Pluta, B., et al. (2010) · Studies in physical Culture &Tourism · Cited by 2
Dopage en pathologie ostéoarticulaire : physiologie et risques
Nielens, H., & Hermans, M. P. (2006) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(06)40631-8 · Cited by 1
Complications cardiovasculaires du dopage
Gauthier, J. (2014) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(14)70632-7 · Cited by 2
Doping und medikamentöse Leistungssteigerung: Nicht nur Anabolika und nicht nur im Sport
Raber, W. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
Kovár, P. (2008) · Cited by 2
Addiction to Anabolic-Androgenic Steroids
Maini, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-57159-6_8-1 · Cited by 1
Complications cardiovasculaires du dopage
Gauthier, J. (2014) · Science & Sports · doi:10.1016/j.scispo.2014.07.011 · Cited by 1
Guerras, J. M., Hoyos, J., de la Fuente, L., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168289 · Cited by 1
Unveiling the Impact of Nandrolone Decanoate on Kidney and Heart of Rattus Norvegicus
Abbas, A. S., Akram, M. N., Nisa, W. U., et al. (2024) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i1.533 · Cited by 1
Health, Risk-Taking Behavior and Sexuality in Swedish Adolescents
Holmberg, L. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Besonderheiten bei Mißbrauch und Abhängigkeiten
Wolter-Henseler, D. K., Jage, J., Meermann, R., & Fromme, A. (2001) · Springer eBooks · doi:10.1007/978-3-642-59535-6_17 · Cited by 1
Salt, Diet, and Metabolic Factors Affecting Breastfeeding
Verd, S. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-224-7_18
What Is Known About Doping and What Can This Study Add to It?
Paoli, L., & Donati, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8241-3_1
“Street” and Prescription Drug Abuse
Kelley, S. S., Godin, J. R. P., & Christie, J. G. (2015) · John Wiley & Sons, Inc. eBooks · doi:10.1002/9781118834015.ch116
Dopaje y patología osteoarticular: fisiología y riesgos
Nielens, H., & Hermans, M. P. (2007) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(07)70955-3
Loraschi, A. (2013) · IrInSubria (University of Insubria)
Barros, D. D., da Silva, V. C., da Silva, I. A., et al. (2014)
Exercise, Conditioning, and Performance
Bookspan, J. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03228-5.50091-4
Bahr, R. (2003) · doi:10.1002/9780470693902.ch19
Bodybuilding und Muskelaufbaupräparate
Richter, M., & Pöhlmann, K. (2013) · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks · doi:10.32745/9783954661060-18
Increments in virulence of Candida albicans induced by androgenic anabolic steroids
Ribas, C., Rymovicz, A. U. M., Rosa, R. T., Peña, L. C., Bianchini, L. F., & Rosa, E. A. R. (2019) · Steroids · doi:10.1016/j.steroids.2019.108501
Todesfälle bei Anabolikamissbrauch - Todesursache, Befunde und rechtsmedizinische Aspekte 1
Gilg, T., Büttner, A., Kistler, P., et al. (2003)
(2003) · CRC Press eBooks · doi:10.1201/9780203634530.bmatt
Immune-Endocrine Perspectives of Breast Cancer
Saini, K. S., Suman, S., & Konwar, R. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681089522112010005
Sleep pathology and use of anabolic androgen steroids among male weightlifters in NorwayPreprint
Klonteig, S., Scarth, M., & Bjørnebekk, A. (2023) · doi:10.31234/osf.io/ntdsu
RELATIONSHIP OF FEMALE BREASTS TO PHYSICAL ACTIVITY, EXERCISE AND SPORT – PART 2
Lombardi, J. A., Corrêa, R. P. F., Silva, R. N., et al. (2023) · Revista Brasileira de Medicina do Esporte · doi:10.47870/1517-869220243003279514i
RELAÇÃO DAS MAMAS FEMININAS COM A ATIVIDADE FÍSICA, EXERCÍCIO E ESPORTE – PARTE 2
Lombardi, J. A., Corrêa, R. P. F., Silva, R. N., et al. (2023) · Revista Brasileira de Medicina do Esporte · doi:10.47870/1517-869220243003279514p
Klonteig, S., Scarth, M., & Bjørnebekk, A. (2024) · Figshare · doi:10.6084/m9.figshare.25045436
Metadata
- Authors
- Korkia, P., & Stimson, G.
- ORCID
- Stimson, G.
- Venue
- International Journal of Sports Medicine
- Publisher
- Georg Thieme Verlag KG
- Published
- 1997-10
- Volume
- 18
- Issue
- 07
- Pages
- 557-562
- ISSN
- 0172-4622 (ISSN-L)
- 1439-3964
- OpenAlex
- W2020732406
- Cited by
- 143
- References
- 0
- Citations by year
- 2025: 1 · 2024: 6 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 6
- FWCI
- 18.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Sports Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Kent
- Topics
- Social Sciences › Sociology and Political Science › Doping in Sports
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Keywords
- anabolic steroids, prevalence, gym members, self-injection, polydrug use, corticosteroid adverse effects, testicular atrophy, gynecomastia, menstrual irregularity, sleep disorders, Great Britain
- MeSH terms
- Administration, Oral, Adult, Atrophy, Attitude to Health, Breast, Clitoris, Common Cold, Doping in Sports, Drug Combinations, Edema, Epistaxis, Female, United Kingdom, Gymnastics, Gynecomastia, Humans, Hypertension, Hypertrophy, Injections, Kidney Diseases, Health Knowledge, Attitudes, Practice, Liver Diseases, Male, Menstruation Disturbances, Public Health, Sleep Wake Disorders, Sports, Tendon Injuries, Testis, Prevalence, Anabolic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review